Cipher Pharmaceuticals Stock Z Score
CPHRFDelisted Stock | USD 2.57 0.00 0.00% |
Cipher |
Cipher Pharmaceuticals OTC Stock Z Score Analysis
Cipher Pharmaceuticals' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Cipher Pharmaceuticals Z Score | 75.6 |
Most of Cipher Pharmaceuticals' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cipher Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, Cipher Pharmaceuticals has a Z Score of 75. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The z score for all United States stocks is notably lower than that of the firm.
Cipher Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cipher Pharmaceuticals' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cipher Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cipher Pharmaceuticals by comparing valuation metrics of similar companies.Cipher Pharmaceuticals is currently under evaluation in z score category among its peers.
Cipher Fundamentals
Return On Equity | 0.24 | ||||
Return On Asset | 0.15 | ||||
Profit Margin | 0.45 % | ||||
Operating Margin | 0.57 % | ||||
Current Valuation | 46.13 M | ||||
Shares Outstanding | 25.12 M | ||||
Shares Owned By Insiders | 44.12 % | ||||
Number Of Shares Shorted | 11.43 K | ||||
Price To Earning | 15.54 X | ||||
Price To Book | 1.63 X | ||||
Price To Sales | 3.28 X | ||||
Revenue | 21.94 M | ||||
Gross Profit | 18.26 M | ||||
EBITDA | 11.85 M | ||||
Net Income | 7.76 M | ||||
Cash And Equivalents | 24.19 M | ||||
Cash Per Share | 0.96 X | ||||
Total Debt | 507 K | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 2.51 X | ||||
Book Value Per Share | 1.77 X | ||||
Cash Flow From Operations | 13.81 M | ||||
Short Ratio | 0.97 X | ||||
Earnings Per Share | 0.36 X | ||||
Target Price | 5.59 | ||||
Number Of Employees | 26 | ||||
Beta | 1.03 | ||||
Market Capitalization | 64.32 M | ||||
Total Asset | 51.65 M | ||||
Z Score | 75.6 | ||||
Net Asset | 51.65 M |
About Cipher Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cipher Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cipher Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cipher Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Cipher OTC Stock
If you are still planning to invest in Cipher Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cipher Pharmaceuticals' history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |